88962-41-8 Usage
Uses
Used in Pharmaceutical Industry:
L-Leucine, N-L-phenylalanyl-, 2-bromoethyl ester, monohydrobromide is used as a reagent in the synthesis of peptides and proteins for the development of new pharmaceuticals. Its ability to promote protein synthesis and muscle growth makes it a valuable ingredient in the creation of medications targeting muscle wasting conditions and other related health issues.
Used in Biochemistry Research:
In the field of biochemistry, L-Leucine, N-L-phenylalanyl-, 2-bromoethyl ester, monohydrobromide is utilized as a research tool to study the mechanisms of protein synthesis and muscle growth. Its application aids in understanding the fundamental processes of these biological functions, which can contribute to the advancement of knowledge and potential therapeutic interventions.
Used in Molecular Biology Research:
L-Leucine, N-L-phenylalanyl-, 2-bromoethyl ester, monohydrobromide is also employed in molecular biology research to explore the interactions between amino acids and their role in the formation and function of proteins. L-Leucine, N-L-phenylalanyl-, 2-bromoethyl ester, monohydrobromide's properties make it instrumental in investigating the molecular mechanisms underlying various biological processes and diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 88962-41-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,8,9,6 and 2 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 88962-41:
(7*8)+(6*8)+(5*9)+(4*6)+(3*2)+(2*4)+(1*1)=188
188 % 10 = 8
So 88962-41-8 is a valid CAS Registry Number.
88962-41-8Relevant academic research and scientific papers
Glycopeptide Synthesis: Selective C-terminal Deblocking and Peptide Chain Elongation of Glucosylserine Derivatives
Buchholz, Michael,Kunz, Horst
, p. 1859 - 1885 (2007/10/02)
Benzyloxycarbonyl-(Z-)serine 2-bromoethyl ester (3b) reacts with 2,3,4,6-tetra-O-benzoyl-α-D-glucopyranosyl bromide (14) to give the glucosylserine ester 15.After conversion into the corresponding 2-iodoethyl ester 23 the carboxylic group is deblocked selectively by reductive elimination using zinc.In this procedure the Z and the carbohydrate protective functions as well as the sensitive O-glycoside bond remain unaffected.The glycosylserine 24 is condensed with amino acid 2-bromoethyl esters 2 to form protected glycodipeptide 2-bromoethyl esters 18 which are extended to give glycotripeptide esters 25 after selective carboxyl deblocking.Whereas protected serine dipeptides 5 are glycosylated with 14 to form the conjugates 18, the glycosylation of the serine tripeptides 10 was not successful.
